Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.33 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.33 |
| ▸ | TAS1R2 | Q8TE23 | 2/20 | 0.33 |
| ▸ | EBP | Q15125 | 1/20 | 0.33 |
| ▸ | DHCR7 | Q9UBM7 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 5/20 | 0.32 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.31 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.30 |
| ▸ | KDM4B | O94953 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7759488 | 0.84 | TAS1R3 (0.33) | ALDH1A1POLBMAPTHTTSMN1; SMN2 | |
| SCHEMBL19442592 | 0.76 | ALDH1A1 (0.33) | ALDH1A1POLBMAPTHTTSMN1; SMN2 | |
| SCHEMBL20980046 | 0.73 | EPHX2 (0.32) | ALDH1A1POLBMAPTHTTSMN1; SMN2 | |
| SCHEMBL920182 | 0.70 | TAS1R3 (0.36) | ALDH1A1POLBMAPTHTTSMN1; SMN2 | |
| SCHEMBL1011133 | 0.69 | POLB (0.42) | ALDH1A1POLBMAPTHTTSMN1; SMN2 | |
| SCHEMBL10029427 | 0.69 | HRH3 (0.37) | ALDH1A1POLBMAPTHTTSMN1; SMN2 | |
| SCHEMBL20049839 | 0.69 | MEN1 (0.33) | ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL23087149 | 0.68 | HRH3 (0.33) | ALDH1A1POLBMAPTHTTSMN1; SMN2 | |
| SCHEMBL21959258 | 0.68 | HRH3 (0.36) | ALDH1A1POLBMAPTHTTSMN1; SMN2 | |
| SCHEMBL21562371 | 0.67 | ALDH1A1 (0.36) | ALDH1A1POLBMAPTHTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2004519566-A | — | — | 2004-07-02 | — | — | JP | claimed |
| EP-1363967-A2 | IMPROVED FIBER SUBSTRATE ADHESION AND COATINGS BY METATHESIS POLYMERIZATION | Lord Corporation (US) | 2003-11-26 | — | — | EP | claimed |
| WO-2002077078-A2 | IMPROVED FIBER SUBSTRATE ADHESION AND COATINGS BY METATHESIS POLYMERIZATION | LORD CORPORATION (US) | 2002-10-03 | — | — | WO | claimed |
| WO-2001072421-A1 | POLYMER SUPPORTED CATALYSTS FOR OLEFIN METATHESIS | GLAXO GROUP LIMITED (GB) | 2001-10-04 | — | — | WO | claimed |
| EP-4367109-A1 | PROCESS FOR PREPARING PERFUMING INTERMEDIATES | Firmenich SA (CH) | 2024-05-15 | — | — | EP | disclosed |
| WO-2023036732-A1 | PROCESS FOR PREPARING PERFUMING INTERMEDIATES | FIRMENICH SA (CH) | 2023-03-16 | — | — | WO | disclosed |
| WO-2014022752-A1 | MACROCYCLES AS PIM INHIBITORS | AMGEN INC. (US) | 2014-02-06 | — | — | WO | disclosed |
| EP-2089020-A1 | MACROCYCLIC PEPTIDES AS HEPATITIS C VIRUS INHIBITORS | Brystol-Myers Squibb Company (US) | 2009-08-19 | — | — | EP | disclosed |
| WO-2008064057-A1 | MACROCYCLIC PEPTIDES AS HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-05-29 | — | — | WO | disclosed |
| EP-1817097-A2 | MEMBRANE SEPARATION OF A METATHESIS REACTION MIXTURE | Dow Gloval Technologies Inc. (US) | 2007-08-15 | — | — | EP | disclosed |
| WO-2006047105-A2 | MEMBRANE SEPARATION OF A METATHESIS REACTION MIXTURE | DOW GLOBAL TECHNOLOGIES, INC. (US) | 2006-05-04 | — | — | WO | disclosed |
| WO-2006045070-A2 | PEG-SUBSTITUTED PYRIDINE LIGANDS AND RELATED WATER-SOLUBLE CATALYSTS | UNIVERSITY OF MASSACHUSETTS (US) | 2006-04-27 | — | — | WO | disclosed |
| EP-1450784-A4 | HSP90-INHIBITING ZEARALANOL COMPOUNDS AND METHODS OF PRODUCING AND USING SAME | CONFORMA THERAPEUTICS CORP (US) | 2005-02-09 | — | — | EP | disclosed |
| EP-1450784-A2 | HSP90-INHIBITING ZEARALANOL COMPOUNDS AND METHODS OF PRODUCING AND USING SAME | Conforma Therapeutics Corporation (US) | 2004-09-01 | — | — | EP | disclosed |
| EP-1434816-A1 | CONTACT METATHESIS POLYMERIZATION | Lord Corporation (US) | 2004-07-07 | — | — | EP | disclosed |
| WO-2003041643-A2 | HSP90-INHIBITING ZEARALANOL COMPOUNDS AND METHODS OF PRODUCING AND USING SAME | CONFORMA THERAPEUTICS CORPORATION (US) | 2003-05-22 | — | — | WO | disclosed |
| WO-2003031505-A1 | CONTACT METATHESIS POLYMERIZATION | LORD CORPORATION (US) | 2003-04-17 | — | — | WO | disclosed |
| WO-2001072421-A1 | POLYMER SUPPORTED CATALYSTS FOR OLEFIN METATHESIS | GLAXO GROUP LIMITED (GB) | 2001-10-04 | — | — | WO | disclosed |